1. Home
  2. EPRT vs RYTM Comparison

EPRT vs RYTM Comparison

Compare EPRT & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Essential Properties Realty Trust Inc.

EPRT

Essential Properties Realty Trust Inc.

HOLD

Current Price

$25.61

Market Cap

6.9B

Sector

Real Estate

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

BUY

Current Price

$90.28

Market Cap

5.8B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
EPRT
RYTM
Founded
2016
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
5.8B
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
EPRT
RYTM
Price
$25.61
$90.28
Analyst Decision
Strong Buy
Buy
Analyst Count
20
18
Target Price
$36.20
★ $138.59
AVG Volume (30 Days)
★ 1.9M
616.9K
Earning Date
10-21-2026
11-03-2026
Dividend Yield
★ 4.99%
N/A
EPS Growth
11.30
★ 28.34
EPS
★ 0.62
N/A
Revenue
★ $561,219,000.00
N/A
Revenue This Year
$19.04
$65.10
Revenue Next Year
$15.71
$78.21
P/E Ratio
$41.35
★ N/A
Revenue Growth
★ 24.82
N/A
52 Week Low
$25.37
$74.50
52 Week High
$34.73
$122.20

Technical Indicators

Market Signals
Indicator
EPRT
RYTM
Relative Strength Index (RSI) 17.54 25.33
Support Level N/A $82.43
Resistance Level $31.49 $92.51
Average True Range (ATR) 0.52 3.53
MACD -0.05 -0.53
Stochastic Oscillator 8.69 7.14

Price Performance

Historical Comparison
EPRT
RYTM

About EPRT Essential Properties Realty Trust Inc.

Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. The Company generally invests in and leases freestanding, single-tenant commercial real estate facilities where a tenant services its customers and conducts activities that are essential to the generation of the tenant's sales and profits.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: